Declassify the world's first ATAC-seq and CUT-Tag joint application to reveal a new mechanism for tumor immune escape.
Time of Update: 2020-07-22
process (including pass-down regulatory elements and transcription factors). . ChIP-seq experiment needs to be cell formaldehyde fixed, ultrasonic crushing, and other column operations, the amount of cell requirements is relatively
Tag pharma and baijiahui signed a cooperation agreement on clinical trial research and development of innovative drugs and medical devices
Time of Update: 2020-04-03
(hereinafter referred to as "baijiahui") have reached a consensus on the clinical trial research and development cooperation of innovative drugs and medical devices and signed the strategic cooperation agreement, which is valid for 5 years.
Tag Pharma plans to acquire part of the equity of Japanese EPS with us $17.7433 million!
Time of Update: 2019-10-30
On October 30, tag Pharma announced that its wholly-owned subsidiary, Hong Kong tag Pharma Technology Co., Ltd
(hereinafter referred to as "Hong Kong tag") intends
Report card of zaiding pharmaceutical H1: net income in the first half of the year was 3.4 million
Time of Update: 2019-09-04
On September 3, 2019, zaiding pharmaceutical announced its financial report and business progress for the first half of June 30, 2019: Dr
Du Ying, founder and chief
New ranking of top 10 pharmaceutical companies! H1 has a total revenue of nearly US $200 billion, with a total of 3587 clinical studies focusing on tumors
Time of Update: 2019-08-09
In addition to opdivo, eliquis, another star drug of BMS, also performed well in the first half of the year, with a total sales volume of $3.97 billion, an increase of $810 million compared with 2018h1.
Take stock of H1 global biopharmaceutical and technological fields, 10 financing opportunities, 3 seats for China
Time of Update: 2018-08-01
Gen, an authoritative global biotechnology media, recently released the financing report of biopharmaceutical, diagnostic and therapeutic technology companies in the early stage
Rapid growth of clinical trial consulting business of tag
Time of Update: 2014-08-21
Smo (clinical trial site management organization) will also be one of the company's key development businesses, with revenue of 13.66 million yuan in the first half of the year, an increase of 119%.